Registry for patients with pancreatic diseases
Official title: Pancreas Disease and High Risk Registry
Run by Icahn School of Medicine at Mount Sinai · NCT02775461 · Data updated 2026-11-12
This study is creating a registry to collect information from patients with pancreatic diseases to help researchers understand what causes these conditions and how to prevent them.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 1368 (estimated) |
| Sponsor | Icahn School of Medicine at Mount Sinai Academic / other |
| Locations | 2 sites (New York, New York and 1 other locations) |
| Status | Recruiting |
| Started | March 1, 2013 |
| Main results expected | January 2033 |
| Study ends | January 2033 |
| Registry record updated | February 11, 2026 |
| Trial ID | NCT02775461 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this registry include individuals with a family history of pancreatic cancer, specific genetic mutations associated with increased risk, or those with pancreatic cysts measuring 1 cm or larger.
✕Probably not a fit
Patients who do not have a family history of pancreatic cancer or related genetic predispositions may not benefit from this registry.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This project aims to establish a comprehensive registry of patients diagnosed with various pancreatic diseases, including pancreatic cancer, precancerous lesions, and chronic pancreatitis. The registry will collect detailed data on personal and family medical histories, demographics, and risk factors to better understand the development of pancreatic cancer and related conditions. By gathering this information, researchers hope to identify patterns and risk factors that contribute to pancreatic diseases, ultimately aiding in prevention and prognosis efforts.
Why it matters
Potential benefit: If successful, this registry could lead to improved understanding and management of pancreatic diseases, potentially enhancing early detection and prevention strategies for patients at risk.
How similar studies have gone: While this registry approach is not novel, it builds on previous efforts to understand pancreatic diseases, which have shown promise in identifying risk factors and improving patient outcomes.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * At least 1 first degree relative affected with Pancreatic Cancer * Any of (BRCA1, BRCA2, PALB2, ATM) mutations + 1 family member with Pancreatic Cancer * mFAMMM (p16,CDKN2A mutations) + 1 family member with Pancreatic cancer * Known mutation carrier for STK11 (Peutz Jeghers Syndrome) * Lynch syndrome (HNPCC) + 1 family PDAC * Known mutation carrier for Hereditary pancreatitis * Individuals with a history of pancreatic cyst(s) (IPMN's) that measure ≥ 1 cm Exclusion Criteria: * Patients who do not speak English or Spanish * Refusal by patient * Individuals under the age of 18 years
Where it's running
-
Mount Sinai West
New York, New York, United States Recruiting -
Icahn School of Medicine at Mount Sinai
New York, New York, United States Recruiting
Study contacts
- Principal investigator: Aimee Lucas, MD, MS — Icahn School of Medicine at Mount Sinai
- Study coordinator: Joyce Serebrenik
- Email: joyce.serebrenik@mountsinai.org
- Phone: (212) 241-7269
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Scrambler therapy for chronic pancreatitis pain
We will test whether Scrambler Therapy can reduce persistent abdominal pain in adults with chronic pancreatitis who haven't found relief from standard treatments.
-
Patient-reported outcomes after pancreatic surgery
This project will see how pancreatic surgery affects quality of life and whether adults who have pancreatic resection feel satisfied with their decision over time.
-
Internet program for managing pain in pancreatitis patients
This study is testing an online program that helps people with pancreatitis manage their pain better and improve their quality of life.
-
Evaluating the progression of pancreatitis from acute to chronic stages
This study is trying to see how acute pancreatitis can turn into chronic pancreatitis over time by following patients with different stages of the condition and using advanced imaging and tests.
-
Developing a blood test for early diagnosis of pancreatic cancer
This study is trying to develop a simple blood test to help find pancreatic cancer early and track how well treatments are working for patients.
-
CBT-248 safety in healthy adults for chronic pancreatitis support
This early study tests CBT-248 in healthy adults to see if it is safe, how it behaves in the body, and whether meals affect its levels.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.